ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma

MLA

Yalu Liu, et al. “ITK Inhibition Induced in Vitro and in Vivo Anti-Tumor Activity through Downregulating TCR Signaling Pathway in Malignant T Cell Lymphoma.” Cancer Cell International, vol. 19, no. 1, Feb. 2019, pp. 1–19. EBSCOhost, https://doi.org/10.1186/s12935-019-0754-9.

APA

Yalu Liu, Xiaogan Wang, Lijuan Deng, Lingyan Ping, Yunfei Shi, Wen Zheng, Ningjing Lin, Xiaopei Wang, Meifeng Tu, Yan Xie, Weiping Liu, Zhitao Ying, Chen Zhang, Zhengying Pan, Xi Wang, Ning Ding, Yuqin Song, & Jun Zhu. (2019). ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma. Cancer Cell International, 19(1), 1–19. https://doi.org/10.1186/s12935-019-0754-9

Chicago

Yalu Liu, Xiaogan Wang, Lijuan Deng, Lingyan Ping, Yunfei Shi, Wen Zheng, Ningjing Lin, et al. 2019. “ITK Inhibition Induced in Vitro and in Vivo Anti-Tumor Activity through Downregulating TCR Signaling Pathway in Malignant T Cell Lymphoma.” Cancer Cell International 19 (1): 1–19. doi:10.1186/s12935-019-0754-9.